80 results
S-8
SPRY
ARS Pharmaceuticals Inc
21 Mar 24
Registration of securities for employees
5:08pm
Amount of
Registration
Fee
Equity
Common Stock, par value $0.0001 per share to be issued pursuant to the ARS Pharmaceuticals, Inc. 2020 Equity Incentive … the Registrant’s 2020 Equity Incentive Plan (the “2020 Plan”) and 2020 Employee Stock Purchase Plan, as amended (the “2020 ESPP”) by reason of any stock
S-8
EX-5.1
SPRY
ARS Pharmaceuticals Inc
21 Mar 24
Registration of securities for employees
5:08pm
Equity Incentive Plan (the “Incentive Plan”), (b) 700,000 shares of Common Stock issuable pursuant to the Company’s 2020 Employee Stock Purchase Plan … , (together with the Incentive Plan, the “Plans”).
In connection with this opinion, we have examined and relied upon (a) the Registration Statement
S-8
EX-23.1
SPRY
ARS Pharmaceuticals Inc
21 Mar 24
Registration of securities for employees
5:08pm
(Form S-8) pertaining to the 2018 Equity Incentive Plan, the 2020 Equity Incentive Plan and the 2020 Employee Stock Purchase Plan of ARS Pharmaceuticals
S-8
SPRY
ARS Pharmaceuticals Inc
21 Mar 24
Registration of securities for employees
5:08pm
No.)
11682 El Camino Real, Suite 120
San Diego, California
(Address of Principal Executive Offices)
(Zip Code)
2020 Equity Incentive Plan
2020 Employee … plans are effective.
The registrant previously registered shares of its Common Stock for issuance under the Registrant’s 2020 Equity Incentive Plan
8-K
EX-10.1
lcoa3ydrlx7n5ggfnt
9 Dec 22
Departure of Directors or Certain Officers
5:02pm
8-K
EX-10.8
is806jyo32jq2 mygf
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
8-K
EX-10.9
5exwb2m h2orozu
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
8-K
EX-10.7
gh967o068e
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
8-K
EX-10.10
9al6yd
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
8-K
omod3p5ravp2v1
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
8-K
EX-10.6
rsw9j qi4n7o3azuc
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm